Weaning clinical trials
9 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Effects of GLP-1 RAs on Human Lactation Outcomes
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
- A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
- Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU
- Drug Excretion in Breast Milk
- The Impact of Acute Exercise in the Heat on Breast Milk Production and Composition in Lactating Women
- A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
- RELIANCE: Moringa in Lactation and Early Childhood
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Weaning” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.